NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) on Monday released topline data from pre-specified Alzheimer’s Disease biomarker analyses in the Phase 3 BROADWAY clinical trial. The study was primarily ...

Elderly persons who find it difficult to lift an object weighing 5 kilograms run the risk of developing a host of chronic ...

NewAmsterdam Pharma’s push to show a cholesterol drug can prevent Alzheimer’s disease has passed another test. | NewAmsterdam ...

Shares of NewAmsterdam Pharma rose in premarket trading Monday after finding positive benefits for treating Alzheimer's Disease in its cholesterol drug study. Shares traded 9.2% higher ahead of the ...

Immunologist Professor Luke O'Neill has shared five lifestyle changes that can help lower a person's chance of developing ...

Younger-onset dementia affects an estimated 110 out of every 100,000 people, and having these health conditions can increase ...

While these numbers may sound worrying, the study also gives us hope. It shows that Alzheimer’s risk isn’t only written in ...

New dementia diagnoses have significantly decreased since 2015, a study published in BMJ found.But more people are living ...

A person aged 75 to 80 is less likely to have dementia today compared to someone of the same age several decades ago, a ...

A novel blood test offers affordable early detection of Alzheimer disease, enhancing awareness and intervention opportunities ...

There are now more than 7 million Americans living with Alzheimer’s. In Georgia, 188,000 people have the brain disease.

A diet rich in leafy greens, berries, nuts, and olive oil may help prevent dementia and improve memory, regardless of age, a ...